Brecon Pharma Consulting

Brecon Pharma Consulting is a private pharmaceutical and biotechnology consulting firm founded in 2012 by Margaret R. Dalesandro. The firm appears to provide strategic product development and commercialization consulting to life science companies, with a stated focus on identifying and obtaining critical information early in product development. Public biographies of its founder describe the business as a full-service pharma and biotech consultancy rather than a drug developer. Based on the available evidence, Brecon Pharma Consulting does not appear to own a therapeutic pipeline, platform technology, or proprietary clinical-stage assets; instead, it operates as a specialized advisory business serving the biopharma industry.